How many studies have been conducted on Travoprost?

BiohacksAI has indexed 295 PubMed studies on Travoprost, including 80 randomized controlled trials (RCTs). 73% of studies involve human subjects.

What are the main research areas for Travoprost?

The primary research domains for Travoprost are 👁️ Vision & Eye, 🔬 Inflammation, ❤️ Cardiovascular. This is based on analysis of 295 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Travoprost

A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

295+ PubMed studies analyzed · 80 RCTs · Evidence Score: 58.9

Research Domains

Travoprost has been studied across 10 research domains including 👁️ Vision & Eye, 🔬 Inflammation, ❤️ Cardiovascular, 😴 Sleep, 🔥 Metabolic. The primary research focus is 👁️ Vision & Eye with 75% of studies addressing this area.

Loading evidence profile...

This evidence profile for Travoprost is generated deterministically from 295 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.